Position in ALNY
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$32,286,972
-$12,864,209 QoQ
Shares Held
107,255
-21.4% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#106
of 784 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Handelsbanken Fonder AB holds $686,434,691 across 88 Biotechnology names. ALNY ranks #8 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
218,292 | $108,432,185 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
631,899 | $49,458,734 | |
| 3 | ARGX |
Argenx SE
|
52,653 | $48,849,873 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
212,275 | $39,754,862 | |
| 5 | CYTK |
Cytokinetics Inc
|
405,000 | $34,501,950 | |
| 6 | KRYS |
Krystal Biotech, Inc.
|
90,407 | $33,601,569 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
52,328 | $32,628,601 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
107,255 | $32,286,972 |
All Filings in ALNY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,286,972 | 107,255 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $45,151,181 | 136,462 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $54,153,965 | 136,185 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $70,848,264 | 155,369 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $50,661,994 | 155,362 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $31,506,743 | 116,683 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $12,788,157 | 54,346 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $20,126,970 | 73,181 | Shares | Sole | 2024-10-04 | |
| 2024-06-30 | $17,751,393 | 73,051 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $11,224,591 | 75,106 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $14,336,226 | 74,898 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $30,061,485 | 169,743 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $32,222,181 | 169,644 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $34,312,612 | 171,289 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $45,698,669 | 192,294 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $25,539,014 | 127,593 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $25,086,200 | 172,000 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $27,987,906 | 171,400 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $31,847,124 | 187,800 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $3,795,081 | 20,100 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $3,237,832 | 19,100 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $2,866,157 | 20,300 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $2,820,349 | 21,700 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $2,795,520 | 19,200 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,843,712 | 19,200 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||